Severe Pneumonia: Testing Trimodulin

We are studying whether trimodulin can improve survival in hospitalized adults with severe pneumonia compared to a placebo. The trial also looks at the safety and effects of the treatment.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Human Albumin Solution
Human albumin solution is a blood-derived protein that restores blood volume and maintains fluid balance in those with low blood protein or severe fluid loss.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Trimodulin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medizinische Universitaet Innsbruck
Univ. Klinik fuer Innere Medizin I
Innsbruck, Austria
Landeskrankenanstalten-Betriebsgesellschaft Kabeg
ZISOP Schmerzambulanz
Klagenfurt am Wörthersee, Austria
Medical University Of Vienna
Department of Medicine I, Intensive Care Unit 13i2
Vienna, Austria

Sponsor: BIOTEST AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.